BIO logo

Bio-Rad Laboratories, Inc. (BIO) return on equity

annual ROE:

-24.09%-17.15%(-247.12%)
December 31, 2024

Summary

  • As of today (September 11, 2025), BIO annual return on equity is -24.09%, with the most recent change of -17.15% (-247.12%) on December 31, 2024.
  • During the last 3 years, BIO annual ROE has fallen by -60.20% (-166.71%).
  • BIO annual ROE is now -149.48% below its all-time high of 48.69%, reached on December 31, 2020.

Performance

1-year change

-247.12%

3-year change

-166.71%

5-year change

-166.95%

15-year change

-642.57%

BIO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

60.41%
BIO annual return on equity is higher than 60.41% of companies in Healthcare sector

Range

All-time high

48.69%
BIO annual return on equity is currently -149.48% below its historical high of 48.69%

3-year low

-31.14%

Earnings dates

Last annual earnings report date

Dec 31, 2024
BIO previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
BIO next annual earnings announcement has not yet been scheduled

OtherBIOprofitability metrics

Annual revenue

$2.57B
BIO annual revenue is $2.57 billion

annual net income

-$1.84B
BIO annual net profit is -$1.84 billion

Annual EPS

$0.00
BIO annual earnings per share is $0.00

Annual ROA

-17.03%
BIO annual return on assets is -17.03%

quarterly ROE:

4.61%+34.20%(+115.58%)
June 30, 2025

Summary

  • As of today (September 11, 2025), BIO quarterly return on equity is 4.61%, with the most recent change of +34.20% (+115.58%) on June 30, 2025.
  • Over the past year, BIO quarterly ROE has increased by +20.61% (+128.81%).
  • BIO quarterly ROE is now -92.21% below its all-time high of 59.20%, reached on September 30, 2021.

Performance

3-month change

+115.58%

1-year change

+128.81%

3-year change

+128.44%

5-year change

-85.78%

BIO quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

74.61%
BIO quarterly return on equity is higher than 74.61% of companies in Healthcare sector

Range

All-time high

59.20%
BIO quarterly return on equity is currently -92.21% below its historical high of 59.20%

3-year low

-53.27%

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
BIO previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
BIO next earnings announcement is scheduled for Oct 30, 2025

OtherBIOprofitability metrics

Quarterly revenue

$651.60M
BIO quarterly revenue is $651.60 million

quarterly net income

$317.80M
BIO quarterly net profit is $317.80 million

Quarterly EPS

$0.00
BIO quarterly earnings per share is $0.00

Quarterly ROA

3.23%
BIO quarterly return on assets is 3.23%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

annual ROE

-24.09%
BIO annual return on equity is -24.09%

annual net income

-$1.84B
BIO annual net profit is -$1.84 billion

annual shareholders equity

$6.57B
BIO annual stockholders equity is $6.57 billion

BIO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-247.1%+128.8%
3 y3 years-166.7%+128.4%
5 y5 years-166.9%-85.8%

BIO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-166.7%+22.6%at high+108.7%
5 y5-year-149.5%+22.6%-92.2%+108.7%
alltimeall time-149.5%+22.6%-92.2%+108.7%

BIO ROE History

DateAnnualQuarterly
Jun 2025
-
4.61%(-115.6%)
Mar 2025
-
-29.59%(+24.0%)
Dec 2024
-24.09%(+247.1%)
-23.87%(+148.1%)
Sep 2024
-
-9.62%(-39.9%)
Jun 2024
-
-16.00%(+340.8%)
Mar 2024
-
-3.63%(-48.7%)
Dec 2023
-6.94%(-77.7%)
-7.08%(+297.8%)
Sep 2023
-
-1.78%(-62.4%)
Jun 2023
-
-4.74%(+132.4%)
Mar 2023
-
-2.04%(-94.3%)
Dec 2022
-31.14%(-186.2%)
-35.66%(-33.1%)
Sep 2022
-
-53.27%(+228.6%)
Jun 2022
-
-16.21%(+1951.9%)
Mar 2022
-
-0.79%(-102.3%)
Dec 2021
36.11%(-25.8%)
34.76%(-41.3%)
Sep 2021
-
59.20%(+41.3%)
Jun 2021
-
41.91%(-12.1%)
Mar 2021
-
47.69%(-4.5%)
Dec 2020
48.69%(+35.3%)
49.94%(-5.4%)
Sep 2020
-
52.77%(+62.7%)
Jun 2020
-
32.43%(+13.1%)
Mar 2020
-
28.68%(-17.6%)
Dec 2019
35.98%(+242.0%)
34.82%(+357.0%)
Sep 2019
-
7.62%(-59.5%)
Jun 2019
-
18.82%(+51.4%)
Mar 2019
-
12.43%(+44.5%)
Dec 2018
10.52%(+136.9%)
8.60%(-73.3%)
Sep 2018
-
32.23%(+10.9%)
Jun 2018
-
29.06%(+19.7%)
Mar 2018
-
24.28%(+451.8%)
Dec 2017
4.44%(+331.1%)
4.40%(+537.7%)
Sep 2017
-
0.69%(+21.1%)
Jun 2017
-
0.57%(-46.7%)
Mar 2017
-
1.07%(-1.8%)
Dec 2016
1.03%(-78.7%)
1.09%(-71.6%)
Sep 2016
-
3.84%(-1.8%)
Jun 2016
-
3.91%(-12.5%)
Mar 2016
-
4.47%(-7.8%)
Dec 2015
4.84%(+19.2%)
4.85%(+7.3%)
Sep 2015
-
4.52%(+4.4%)
Jun 2015
-
4.33%(-4.4%)
Mar 2015
-
4.53%(+12.4%)
Dec 2014
4.06%(+9.4%)
4.03%(+10.7%)
Sep 2014
-
3.64%(+29.1%)
Jun 2014
-
2.82%(-6.6%)
Mar 2014
-
3.02%(-18.4%)
Dec 2013
3.71%(-57.5%)
3.70%(-15.5%)
Sep 2013
-
4.38%(-37.4%)
Jun 2013
-
7.00%(-11.2%)
Mar 2013
-
7.88%(-9.7%)
Dec 2012
8.73%(-19.5%)
8.73%(-12.6%)
Sep 2012
-
9.99%(-4.1%)
Jun 2012
-
10.42%(+2.1%)
Mar 2012
-
10.21%(-4.6%)
Dec 2011
10.84%(-18.3%)
10.70%(-8.3%)
Sep 2011
-
11.67%(-4.5%)
Jun 2011
-
12.22%(-4.8%)
Mar 2011
-
12.84%(-5.9%)
Dec 2010
13.26%(+4.4%)
13.64%(+13.2%)
Sep 2010
-
12.05%(-0.9%)
Jun 2010
-
12.16%(-4.4%)
Mar 2010
-
12.72%(-1.7%)
Dec 2009
12.70%(+34.2%)
12.94%(+38.4%)
Sep 2009
-
9.35%(+7.2%)
Jun 2009
-
8.72%(-6.1%)
Mar 2009
-
9.29%(+2.5%)
Dec 2008
9.46%(-8.4%)
9.06%(-19.0%)
Sep 2008
-
11.18%(-1.1%)
Jun 2008
-
11.31%(+13.8%)
Mar 2008
-
9.94%(-4.5%)
Dec 2007
10.33%(-26.1%)
10.41%(-7.8%)
Sep 2007
-
11.29%(+0.5%)
Jun 2007
-
11.23%(-11.0%)
Mar 2007
-
12.62%(-9.1%)
Dec 2006
13.97%(+13.0%)
13.88%(-1.5%)
Sep 2006
-
14.09%(+2.7%)
Jun 2006
-
13.72%(+12.9%)
Mar 2006
-
12.15%(-1.1%)
Dec 2005
12.36%(+1.9%)
12.29%(-7.7%)
Sep 2005
-
13.31%(+10.1%)
Jun 2005
-
12.09%(-6.3%)
Mar 2005
-
12.90%(+6.4%)
Dec 2004
12.13%
12.12%(-8.0%)
DateAnnualQuarterly
Sep 2004
-
13.17%(-8.6%)
Jun 2004
-
14.41%(-6.2%)
Mar 2004
-
15.36%(-11.2%)
Dec 2003
17.33%(-14.9%)
17.30%(-2.6%)
Sep 2003
-
17.76%(-13.9%)
Jun 2003
-
20.63%(-1.6%)
Mar 2003
-
20.97%(+3.1%)
Dec 2002
20.36%(+21.7%)
20.33%(-7.6%)
Sep 2002
-
22.01%(+8.7%)
Jun 2002
-
20.25%(+1.7%)
Mar 2002
-
19.92%(+17.7%)
Dec 2001
16.73%(+22.2%)
16.93%(+16.4%)
Sep 2001
-
14.54%(-19.3%)
Jun 2001
-
18.01%(+14.0%)
Mar 2001
-
15.80%(+15.3%)
Dec 2000
13.69%(+153.5%)
13.70%(+187.2%)
Sep 2000
-
4.77%(+914.9%)
Jun 2000
-
0.47%(-72.7%)
Mar 2000
-
1.72%(-67.2%)
Dec 1999
5.40%(-54.4%)
5.24%(-60.4%)
Sep 1999
-
13.23%(+6.2%)
Jun 1999
-
12.46%(+0.8%)
Mar 1999
-
12.36%(+5.8%)
Dec 1998
11.83%(+37.4%)
11.68%(+24.1%)
Sep 1998
-
9.41%(-5.0%)
Jun 1998
-
9.91%(+10.2%)
Mar 1998
-
8.99%(+5.1%)
Dec 1997
8.61%(-46.4%)
8.55%(-13.9%)
Sep 1997
-
9.93%(-18.6%)
Jun 1997
-
12.20%(-10.0%)
Mar 1997
-
13.56%(-10.8%)
Dec 1996
16.06%(-8.4%)
15.20%(-15.6%)
Sep 1996
-
18.01%(+3.9%)
Jun 1996
-
17.34%(-0.7%)
Mar 1996
-
17.46%(+0.5%)
Dec 1995
17.54%(+35.0%)
17.37%(+3.9%)
Sep 1995
-
16.72%(-2.2%)
Jun 1995
-
17.10%(+14.2%)
Mar 1995
-
14.98%(+16.1%)
Dec 1994
12.99%(+403.5%)
12.90%(+42.7%)
Sep 1994
-
9.04%(+52.2%)
Jun 1994
-
5.94%(+58.8%)
Mar 1994
-
3.74%(+52.7%)
Dec 1993
2.58%(-83.6%)
2.45%(-45.1%)
Sep 1993
-
4.46%(-30.9%)
Jun 1993
-
6.45%(-55.6%)
Mar 1993
-
14.53%(-5.6%)
Dec 1992
15.72%(+65.6%)
15.40%(-4.3%)
Sep 1992
-
16.09%(-1.4%)
Jun 1992
-
16.32%(+79.7%)
Mar 1992
-
9.08%(-4.4%)
Dec 1991
9.49%(-33.6%)
9.50%(-21.4%)
Sep 1991
-
12.08%(-1.9%)
Jun 1991
-
12.31%(-9.2%)
Mar 1991
-
13.55%(-4.2%)
Dec 1990
14.29%(-9.6%)
14.15%(+1.9%)
Sep 1990
-
13.89%(-1.6%)
Jun 1990
-
14.11%(-10.4%)
Mar 1990
-
15.74%(-3.6%)
Dec 1989
15.81%(-8.4%)
16.32%(+0.7%)
Sep 1989
-
16.21%(-17.4%)
Jun 1989
-
19.62%(+20.4%)
Mar 1989
-
16.30%(-31.5%)
Dec 1988
17.26%(+4.5%)
23.80%(+28.2%)
Sep 1988
-
18.56%(+4.5%)
Jun 1988
-
17.76%(+3.4%)
Mar 1988
-
17.17%(-21.7%)
Dec 1987
16.51%(-0.9%)
21.94%(+26.7%)
Sep 1987
-
17.32%(+2.7%)
Jun 1987
-
16.86%(+10.6%)
Mar 1987
-
15.24%(-22.0%)
Dec 1986
16.66%(-4.4%)
19.54%(+6.3%)
Sep 1986
-
18.39%(+1.8%)
Jun 1986
-
18.06%(+12.5%)
Mar 1986
-
16.05%(+14.2%)
Dec 1985
17.43%(+74.3%)
14.05%(-46.9%)
Sep 1985
-
26.46%(+28.3%)
Jun 1985
-
20.63%(+39.3%)
Mar 1985
-
14.81%(+55.6%)
Dec 1984
10.00%(+2841.2%)
9.52%
Dec 1983
0.34%(-95.3%)
-
Dec 1982
7.20%(-47.9%)
-
Dec 1981
13.83%(+1.5%)
-
Dec 1980
13.62%
-

FAQ

  • What is Bio-Rad Laboratories, Inc. annual return on equity?
  • What is the all time high annual ROE for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. annual ROE year-on-year change?
  • What is Bio-Rad Laboratories, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. quarterly ROE year-on-year change?

What is Bio-Rad Laboratories, Inc. annual return on equity?

The current annual ROE of BIO is -24.09%

What is the all time high annual ROE for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high annual return on equity is 48.69%

What is Bio-Rad Laboratories, Inc. annual ROE year-on-year change?

Over the past year, BIO annual return on equity has changed by -17.15% (-247.12%)

What is Bio-Rad Laboratories, Inc. quarterly return on equity?

The current quarterly ROE of BIO is 4.61%

What is the all time high quarterly ROE for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high quarterly return on equity is 59.20%

What is Bio-Rad Laboratories, Inc. quarterly ROE year-on-year change?

Over the past year, BIO quarterly return on equity has changed by +20.61% (+128.81%)
On this page